Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma by liquid …

Biomedical chromatography, 2013 - Wiley Online Library
To support pharmacokinetic‐guided dosing in individual patients, a fast and accurate
method for simultaneous determination of anticancer tyrosine kinase inhibitors (TKIs) …
被引用次数：141 相关文章

Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma by liquid …

NAG Lankheet, MJX Hillebrand… - Biomedical …, 2013 - pubmed.ncbi.nlm.nih.gov
To support pharmacokinetic-guided dosing in individual patients, a fast and accurate
method for simultaneous determination of anticancer tyrosine kinase inhibitors (TKIs) …

Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma by liquid …

NAG Lankheet, MJX Hillebrand, H Rosing… - Biomedical …, 2012 - cir.nii.ac.jp
抄録< jats: title> ABSTRACT</jats: title>< jats: p> To support pharmacokinetic‐guided dosing
in individual patients, a fast and accurate method for simultaneous determination of …

Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma by liquid …

NA Lankheet, MJ Hillebrand, H Rosing… - Biomedical …, 2012 - europepmc.org
To support pharmacokinetic-guided dosing in individual patients, a fast and accurate
method for simultaneous determination of anticancer tyrosine kinase inhibitors (TKIs) …

Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma by liquid …

NAG Lankheet, MJX Hillebrand, H Rosing… - Biomedical …, 2013 - infona.pl
To support pharmacokinetic‐guided dosing in individual patients, a fast and accurate
method for simultaneous determination of anticancer tyrosine kinase inhibitors (TKIs) …

[引用][C] Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma …

N Lankheet, MJX Hillebrand, H Rosing, JH Schellens… - 2013 - repository.ubn.ru.nl
To support pharmacokinetic-guided dosing in individual patients, a fast and accurate
method for simultaneous determination of anticancer tyrosine kinase inhibitors (TKIs) …